Loading...
•
Jul 31, 2024
Phreesia Q2 2025 Earnings Report
Phreesia's financial performance improved, with revenue increasing and the company achieving positive free cash flow.
Key Takeaways
Phreesia announced its Q2 Fiscal Year 2025 results, highlighting a 19% year-over-year increase in total revenue to $102.1 million and the achievement of positive free cash flow. The company is maintaining its revenue outlook for fiscal 2025 and updating its Adjusted EBITDA outlook.
Total revenue increased by 19% year-over-year, reaching $102.1 million.
Average number of healthcare services clients (AHSCs) increased by 21% year-over-year, reaching 4,169.
Free cash flow was $3.7 million, compared to negative $15.2 million in the same period of the prior year.
Net loss decreased to $18.0 million, compared to a net loss of $36.8 million in the same period of the prior year.
Revenue by Segment
Forward Guidance
Phreesia is maintaining its revenue outlook for fiscal year 2025 and updating its Adjusted EBITDA outlook.
Positive Outlook
- Maintaining revenue outlook for fiscal 2025 of $416 million to $426 million, implying year-over-year growth of 17% to 20%.
- Updating Adjusted EBITDA outlook for fiscal 2025 to a range of $26 million to $31 million from a previous range of $21 million to $26 million.
- Expect AHSCs to reach approximately 4,200 for fiscal 2025 compared to 3,601 for fiscal 2024.
- Expect Total revenue per AHSC to increase in fiscal 2025 compared to the $98,944 achieved in fiscal 2024.
- Believe that the company's cash and cash equivalents, along with cash generated in normal operations, provide sufficient flexibility to reach fiscal 2025 and fiscal 2026 outlook.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...